O M.S. åîïìïëïãåßôáé...

Boy Ðáßäåò äåí îÝñù ãéáôß ãñÜöù ôçí éóôïñßá ìïõ. AðëÜ Þèåëá íá ôç ìïéñáóôþ ìáæß óáò, åðåéäÞ âëÝðù üôé ðïëý êüóìïò ëÝåé äéÜöïñá åäþ ìÝóá.

ÈõìÜìáé üôé åß÷á ðïëý õøçëü ðõñåôü ìéá åâäïìÜäá êáé äåí Ýðåöôå ìå ôßðïôá. Ôáõôü÷ñïíá ïé ëåìöáäÝíåò ìïõ ðïíïõóáíå ðáñÜ ðïëý êáé äåí ìðïñïýóá íá óçêùèþ áðü ôï êñåâÜôé ãéá 5 - 6 ìÝñåò.
¢ñ÷éóá íá áíçóõ÷þ êáé íá óêÝöôïìáé äéÜöïñá êé Ýôóé áðïöÜóéóá íá ðÜù óå ãéáôñü ãéá åîåôÜóåéò.
ÐÞãá Ýíá ðñùß óôï íïóïêïìåßï ðïõ Ý÷ù ãíùóôïýò ãéáôñïýò ïéêïãåíåéáêÜ.
Åêåß óêÝöôçêá üôé äåí ðñÝðåé íá ðÜù óå áõôïýò êé Ýôóé ðÞãá óå Ýíá åîùôåñéêü éáôñåßï. ÌðÞêá ìÝóá êáé åîÞãçóá óôïí ãéáôñü ôé óõìôþìáôá åß÷á êáé ìïõ Ýãñáøå Ýíá ÷áñôß ãéá íá ðáù íá äþóù áßìá.
¸äùóá áßìá êáé ìïõ åßðáíå óå ìéá åâäïìÜäá íá ðÜù íá ðÜñù ôá áðïôåëÝóìáôá áðü ôï íïóïêïìåßï Þ íá ôïõò ðÜñù ôçëÝöùíï.

ÐÝñáóå ìéá åâäïìÜäá êáé ðÞñá. Ìïõ åßðáíå äåí åßíáé Ýôïéìá ôá áðïôåëÝóìáôá áêüìá. Íá îáíáðÜñù óå Üëëç ìéá åâäïìÜäá. Ðåñßåñãï, äåí Ýäùóá üìùò ìåãÜëç óçìáóßá.
ÎáíáðÞñá êáé ìïõ åßðáíå üôé ðñÝðåé íá îáíáðÜù íá äþóù áßìá, åðåéäÞ ÷Üóáíå ôá áðïôåëÝóìáôá. ÐÜñá ðïëý ðåñßåñãï.
ÐÞãá êáé Ýäùóá ðÜëé áßìá êáé ïé íïóïêüìåò ìå êïéôÜãáíå ðåñßåñãá êáé Ýâáëáí ãÜíôéá üôáí ìïõ ðáßñíáíå ôï áßìá ôþñá.

¸öõãá áðü ôï íïóïêïìåßï êáé óôï äñüìï Üñ÷éóá íá óêÝöôïìáé ôé Ý÷ù êÜíåé ìå ðïéïí êëð. ÖïâÞèçêá ðïëý üôé ìðïñåß íá åßìáé ïñïèåôéêüò.
Êáé åãþ üðùò üëïé ìáò Ý÷ïõìå êÜíåé ôï ëÜèïò íá êÜíïõìå óåî ÷ùñßò êáðüôá Ýóôù êáé ìéá öïñÜ. ÁõôÞ ç öïñÜ ìïõ Ýêïøå ôï êåöÜëé.
ÔÝëïò ðÜíôùí, Þñèå ç óôéãìÞ íá ðÜñù ôá áðïôåëÝóìáôá êáé ìïõ åßðáíå íá ðÜù óôï íïóïêïìåßï.
¹ìïõíá óôçí ðüñôá ôïõ åñãáóôÞñéïõ êáé âãÞêå Ýíáò ãéáôñüò êáé ìïõ åßðå "Á,á åóý åßóáé ìå ôï ôÝôïéï, ðåñßìåíå Ýíá ëåðôü, Ýñ÷ïìáé" ÌðÞêå ìÝóá êáé ìéëïýóå ìå Ýíáí Üëëï ãéáôñü êáé åãþ ôïõò Ýâëåðá êáé Ýôñåìá ïëüêëçñïò.
¹ñèå ìå Ýíáí öÜêåëï óôï ÷Ýñé êáé ìïõ åßðå "ÐÜìå ìáæß óôïí ôñßôï üñïöï íá ìéëÞóåéò ìå Ýíáí ãéáôñü".
Ìïõ åäåéîå Ýíá ãñáöåßï êáé ìïõ åßðå "Ðåñßìåíå åäþ". Ðåñßìåíá Ýíá ôÝôáñôï. Åß÷á áëëÜîåé üëá ôá ÷ñþìáôá. Åß÷á ÷Üóåé ôç Ãç êÜôù áðü ôá ðüäéá ìïõ, Ýôñåìá, Ýêëáéãá, óêåöôüìïõíá äéÜöïñá êáé ðáñáêáëáãá ôï Èåü íá ìçí åßìáé ïñïèåôéêüò.
Ìå öþíáîáí êáé ìðÞêá ìÝóá ¸êáôóá óå ìéá êáñÝêëá Üøõ÷ïò, ìå âëÝììá ðáãùìÝíï.
Ï ãéáôñüò Üíïéîå ôï öÜêåëï ôï äéÜâáóå êáëÜ êáëÜ ìå êïßôáîå óôá ìÜôéá êáé ìïõ åßðå "äõóôõ÷þò åßíáé èåôéêü áãüñé ìïõ!"
Ôï ðåñßìåíá üôé èá ìïõ ðåé áõôü, üìùò äåí Þèåëá íá åßíáé áëÞèåéá!
Åêëáøá ðïëý. Äåí ìðïñïýóå íá ôï ÷ùíÝøåé ôï ìõáëü ìïõ üôé èá ìïõ óõìâåß óôá áëçèåéá.
ÌåôÜ ìïõ ìéëïýóå ãéá ôï ôé êáé ðùò êáé ðïõ ìïõ îáíáðÞñáíå áßìá ãéá ðåñéóóüôåñåò åîåôÜóåéò êáé Ýöõãá.

ÂãÞêá êáé ðÞñá ôïí êáëõôåñï ìïõ ößëï êáé Üñ÷éóá ôá êëÜììáôá. Äåí Þîåñá ôé íá ôïõ ðù, áðëÜ Ýêëáéãá óáí ìùñü.
Áõôüò êáôÜëáâå üôé Ý÷åé âãåé èåôéêü ôï test êáé ðñïóðáèïýóå íá ìå çñåìÞóåé. Ìïõ åßðå íá ðÜù óðßôé ôïõ íá ìéëÞóïõìå.
Ï äñüìïò áðü ôï íïóïêïìåßï ìÝ÷ñé ôï óðßôé ôïõ Þôáíå Üðåéñïò. Äåí ôåëåßùíå ðïôÝ.
¸öôáóá åêåß ìåôÜ áðü 6 þñåò. Åß÷á ðåñðáôÞóåé áðü âüñåéá ìÝ÷ñé íüôéá ÷ùñßò íá ôï êáôáëÜâù.
Åß÷áìå êÜôóåé óôï ìðáëêüíé ìðñïóôÜ óôç èÜëáóóá êáé ôïõ ìéëïýóá ãéá ôá áðïôåëÝóìáôá êëáßãïíôáò.
Áõôüò ðñïóðáèïýóå íá ìå çñåìÞóåé ìïõ Ýëåãå üôé õðÜñ÷ïõí öÜñìáêá êáé üôé äåí èá ðåèÜíù, êëð.
ÌåôÜ ìïõ åßðå üôé êáé ï ãêüìåíïò ôïõ åßíáé (+). ¸ðáèá óïê.
ÓÞìåñá ó÷åäüí Ýíá ÷ñüíï ìåôÜ óõíå÷ßæù íá æù ìå ôç óêÝøç üôé åßìáé ïñïèåôéêüò êáé üôé áõôü äåí èá áëëÜîåé ðïôÝ!
Äåí ìéóü ôïí Üíèñùðï ðïõ ìå êüëëçóå åðßôçäåò ç ìç, áðëÜ Ýðñåðå íá ìïõ ôï åß÷å ðåé.

Ãéá áõôü üëïé üóïé åßóôå êáé ôï îÝñåôå åßíáé êáëü íá ôï ëÝôå, ãéá íá ìçí ÷áëÜôå ôç æùÞ åíüò áíèñþðïõ ÷ùñßò íá öôáßåé ãéá êÜôé êáé ÷ùñßò íá èÝëåé ôï äùñÜêé ðïõ èá ôïõ ÷áñßæåôå. Åßíáé áìáñôßá!
Äåí îÝñù ôé Üëëï íá ðù. ÁðëÜ íá ðñïóÝîåôå ôé êÜíåôå êáé ìå ðïéïí êáé íá ìç ôï ìåôáäßäåôå óå ìéêñÜ ðáéäéÜ. Åßìáóôå áêüìá 21 ìüíï, ãéá íá ìáò ÷áëÜíå ôç æùÞ êÜðïéïé Üññùóôïé óôï ìõáëü. ÍôñïðÞ ôïõò ðïõ ôï êÜíïõí åðßôçäåò ãéá íá êïëëÞóïõí êáé ôïõò Üëëïõò.

ÐáéäéÜ íá óáò ðù ìéá éóôïñßá áðü ôï ðñïçãïýìåíï êáëïêáßñé.
Åßìáóôáí âñÜäõ óå ìéá gay ðáñáëßá êáé Þôáí Ýíáò ôýðïò, ôïí ïðïßï Þîåñá üôé åßíáé (+) êáé ôïí åßäá íá ãáìÜåé Ýíá ðéôóéñßêé ÷ùñßò êáðüôá.
ÐáéäéÜ ôïí Ýóðáóá ôï êåöÜëé ìå Ýíá ìðïêÜëé, äåí Üíôåîá.
Ðùò ìðïñïýí íá õðÜñ÷ïõí ôÝôïéïé Üíèñùðïé; Ôé ôïõ öôáåé ôï ðáéäß êáé ðñÝðåé íá ôïí êïëÞóåé?

×áéñåôþ ôïõò óõìðáèÝóôáôïõò ößëïõò ðïõ óôçñßæïõí ôï óÜéô áõôü!




... 'Aëëåò éóôïñßåò ...



Lancet

Ðñüóöáôåò äçìïóéåýóåéò óôï ðåñéïäéêü The Lancet HIV

Another step towards closing the paediatric treatment gap

Expanding access to antiretroviral therapy (ART) and reducing new HIV acquisitions among women has led to a marked decline in vertical HIV transmission over the past decade. Nevertheless, in 2023 alone, an estimated 120 000 children aged 0–14 years acquired HIV globally, with the vast majority living in Africa.1 Without treatment, over half of infants and young children with perinatally acquired HIV die before their second birthday.2 Early diagnosis and timely linkage to care are therefore essential to reducing morbidity and mortality.

Deworming of filariasis and reduction of HIV incidence

In sub-Saharan Africa, lymphatic filariasis and HIV infection are two major public health problems that often coexist.1 For several decades, scientists have been exploring the negative impact of helminth infections, including the filarial nematode Wucheria bancrofti, on HIV acquisition and pathogenesis.1–3 Immunological studies have tried to validate the anecdotal, but biologically plausible, theory that modulatory effects of helminths such as W bancrofti can affect HIV infection.3–5 However, some of these studies were inconclusive, and many were characterised by two common flaws, cross-sectional design1 or small sample size,3 weakening the strength of the evidence.

Modelling study shows staggering impact of HIV funding cuts

The global AIDS response has seen substantial reductions in HIV incidence and number of deaths.1 The greatest improvements have been recorded in sub-Saharan Africa, the region with the worst HIV burden. Many of the advances are attributed to international funding of national programmes within sub-Saharan Africa. International contributions were estimated to be 41% of total HIV expenditure in low-income and middle-income countries (LMICs) in 2023.1 Over the last 5–10 years there have been reported declines in HIV funding from both domestic contributions and non-US international funders.

About us

Óôï hivaids.gr, öéëïîåíïýìå áöéëïêåñäþò ôï "Ðñüãñáììá Óõíåñãáóßáò" ÌïíÜäùí Ëïéìþîåùí ãéá ôçí áíÜðôõîç äéáäéêôõáêÞò ôñÜðåæáò êëéíéêþí ðáñáìÝôñùí. Ôï Ðñüãñáììá äçìéïõñãÞèçêå áðü Ýíáí ãéáôñü åéäéêü óôçí HIV ëïßìùîç ìå ôç óõììåôï÷Þ ôùí ÌïíÜäùí: Ðåñéóóüôåñá

% Áíáðçñßá êáé HIV

ÍÝïò êáíïíéóìüò

Åíéáßïò Ðßíáêáò Ðñïóäéïñéóìïý Ðïóïóôïý Áíáðçñßáò

Çìåñïëüãéï

@ Äéáýãåéá

ÄéáýãåéáÄé@ýãåéá

äéáöÜíåéá óôï êñÜôïò

ÄéáäéêôõáêÝò áíáñôÞóåéò äéïéêçôéêþí áðïöÜóåùí ãéá ôï HIV/AIDS

¸ñåõíá

Óáò Ý÷åé óðÜóåé ðïôÝ ôï ðñïöõëáêôéêü êáôÜ ôç äéÜñêåéá ìéáò åñùôéêÞò åðáöÞò;
Íáé
¼÷é
Äåí ÷ñçóéìïðïéþ

Åðéêïéíùíßá

Newsletter

Áíáêïéíþóåéò

×ñÞóéìåò ðëçñïöïñßåò

ÔçëåöùíéêÞ ãñáììÞ ãéá ôï HIV/AIDS

210-7222222

ÄåõôÝñá - ÐáñáóêåõÞ
09:00 - 21:00